2020 American Transplant Congress » Poster Session A: Kidney Acute Antibody Mediated Rejection

3:30pm-4:00pm

Are HLA-DQ De Novo Donor-Specific Antibodies a Risk Factor for Acute Humoral Rejection?

R. Hod Dvorai¹, C. A. Hubbell¹, M. R. Laftavi², R. Shahbazov², B. Gallay³, O. G. Pankewycz³

3:30pm-4:00pm

Clinical Significance of C4d and HLA-DSA on Post-Transplant Clinical Outcomes in Kidney Transplant Recipients with Antibody-Mediated Rejection

W. Park, O. Kwon, Y. Kim, J. Paek, K. Jin, S. Park, S. Han

3:30pm-4:00pm

Comparison of Clinical Characteristics and Outcomes of Early Antibody-Mediated Rejection and Late Antibody-Mediated Rejection after Kidney Transplantation

G. Chen, Z. Wu, C. Wang, X. Liu, Q. Li, L. Chen

3:30pm-4:00pm

Daratumumab for Desensitization and Antibody Mediated Rejection Treatment in Highly-HLA Sensitized Patients

S. Jordan, R. Vescio, N. Ammerman, M. Toyoda, S. Ge, M. Chu, J. Hou, E. Huang, A. Peng, S. Sethi, R. Najjar, K. Lim, J. Kobashigawa, J. Patel, E. Kransdorf, A. Vo

3:30pm-4:00pm

Effect of Therapeutic Plasma Exchange on Glomerular Filtration Rate in Patients with Acute Humoral Rejection

M. Maza Moreno, S. Hernandez-Estrada, J. Cano Cervantes, D. Maldonado Tapia, M. Alamilla Sanchez

3:30pm-4:00pm

Epitope Analysis of Complement-Binding De Novo Donor-Specific HLA Class II Antibody

K. Yamanaka, M. Hashimoto, T. Kinoshita, Y. Fujita, S. Matsumura, T. Imanaka, A. Taniguchi, T. Yoshida, H. Kishikawa

3:30pm-4:00pm

Eplet Mismatch Not Correlated with Antibody Mediated Rejection or Allograft Loss Among Kidney Transplant Recipients with De Novo Donor Specific Antibody

A. Basu¹, W. Jiqiu², A. Bentall², M. Gandhi², B. Dukek², N. Henderson², C. Schinstock²

3:30pm-4:00pm

Glomerulitis in One-Hour Biopsy after ABO-Blood Type Incompatible Kidney Transplantation Sensitively Suggests Occurrence of Antibody-Mediated Rejection

D. Iwami, K. Hotta, N. Iwahara, N. Shinohara

3:30pm-4:00pm

Impact of Low Dose Donor Specific Anti-HLA Antibodies between Living Donor versus Deceased Donor Kidney Transplantation

S. Kim¹, S. Lee¹, E. Ko¹, T. Ban², J. Min³, H. Yoon⁴, C. Yang¹, B. Chung¹

3:30pm-4:00pm

Incidence of Antibody Mediated Rejection in Living Kidney Transplant Recipients with Sensitizing History

Y. Kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida², K. Tanabe¹

3:30pm-4:00pm

Large Academic Center Experience with Treatment of Suspected/Confirmed Kidney Transplant Active Antibody Mediated Rejection

J. T. Reece¹, B. A. Steiner², V. Bhoj¹, N. Aqui¹, R. D. Bloom³, J. Trofe-Clark⁴

3:30pm-4:00pm

Preformed Anti-HLA Donor-Specific Antibodies Immunological Risk Assessment: The Importance of HLA Antibody Locus-Specificity

V. Jucaud¹, A. Babu², D. Briggs³, N. Krishnan⁴, D. Mitchell⁵, M. Everly¹

3:30pm-4:00pm

The Clinical Usefulness of Preformed C1q-Binding Donor-Specific Antibodies in Kidney Transplantation

S. Lee, E. Ko, B. Chung, C. Yang

3:30pm-4:00pm

Unusual Case of Delayed Onset Proteinuria in AT1R Antibody Mediated Rejection

K. Venkatachalam, L. Mackelaite, H. Dave